Print Friendly and PDF

Prescription Drugs Feed

Trump overturns program that would offer cheaper prescription drugs to Medicare recipients

If you voted for Donald Trump, did you really think he’d do anything to bring prices down or help people? In an executive order signed Wednesday called “Lowering Prescription Drug Costs for Americans,” President Trump rescinded an executive order by President Joe Biden that would offer a $2 monthly charge... Read more →


Are you still getting a lot of unwanted calls?

On my landline, yes, I still have one, I’m still getting unwanted calls. However, not as many as in the past. The police organization, with the man or men with Texas accents, keep calling, although I told them once to take me off their list. I told them I’d never... Read more →


New guidelines for preventing strokes includes specific risks for women

Updated guidelines for healthcare professionals to use as prevention strategies for people with no history of strokes includes new discoveries that have been made in the last 10 years. They were prepared by the American Stroke Association, a division of the American Heart Association, and published Monday in the association’s... Read more →


Corporate price gouging and inflation: Kamala Harris gets it

About a dozen times I’ve written about price gouging being one of the biggest drivers of inflation, along lamenting about how politicians weren’t talking about it. President Biden took up the topic recently, and Kamala Harris, vice president and the presumptive Democratic nominee for president, announced it Friday as part... Read more →


Money tips for 2024

Every week, I write and send out my newsletter Helpful Money Tips for You. This week’s newsletter has a number of financial tips that will be valuable to to you and your family during 2024. See it below. I’m getting a lot of compliments on the newsletter. People like it because it’s brief and has information from a variety of sources that they can put to use right away. Read more →


Beware: Ozempic and the other new weight-loss drugs have problems

The medical community and consumers are excited about the new injectable weight-loss drugs, such as Ozempic and Wegovy. The drugs suppress appetite and slow digestion. Celebrities, including Orpha Winfrey, are taking the drugs. Most doctors and health care providers like to have a pill or shot that will fix patients’ problems. Read more →


Top consumer and personal finance stories of 2023

It’s that time of year again. It’s unbelievable that 2023 has rolled by so fast. That means that the 2024 election is getting even closer and closer, an election with so many consequences for consumers and their financial lives. As usual, I’m one of the few reporters writing about the top consumer and personal finance stories of the year, research that I enjoy. Read more →


At last: Biden administration takes action on prescription drug price gouging

About 50 percent or more of price increases driving recent inflation is caused from price gouging. On Thursday, finally, President Biden called out the pharmaceutical industry for raising prices too much. Dozens of pharmaceutical companies will be required to pay rebates to Medicare for outrageous price hikes on prescription drugs. Read more →


Inflation eases, despite corporate price gouging

It's amazing that as we’re all suffering from inflation so little is said about corporate price gouging and the role it’s playing in price increases. Fortunately, there’s a watchdog group that keeps researching inflation. Here’s the latest from Accountable.US: The increase in basic prices having risen at the smallest rate since September 2021. Read more →


Full approval of lecanemab to treat Alzheimer’s by the FDA fails patients and the public, consumer group says

The approval of a new drug to treat Alzheimer’s disease is controversial. The U.S. Food and Drug Administration gave full approval to the drug lecanemab (Leqembi) Thursday to treat adults with Alzheimer’s disease. In January, Public Citizen, a consumer advocacy organization, urged the agency not to approve the drug. Read more →